13
views
0
recommends
+1 Recommend
1 collections
    0
    shares

      Call for Papers: Green Renal Replacement Therapy: Caring for the Environment

      Submit here before July 31, 2024

      About Blood Purification: 3.0 Impact Factor I 5.6 CiteScore I 0.83 Scimago Journal & Country Rank (SJR)

      • Record: found
      • Abstract: found
      • Article: found

      How to Best Define Patients with Moderate Chronic Kidney Disease

      research-article

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background: The objective of this study was to identify which formula may best identify moderate chronic kidney disease (CKD) (glomerular filtration rate (GFR) cut-off of 60 ml/min/1.73 m<sup>2</sup>). Methods: We compared the performances of 14 serum creatinine (S<sub>cr</sub>) and 11 cystatin C (Cys C) estimated GFR equations using inulin clearance (Cl<sub>in</sub>) as the reference test in a stable CKD population of 101 patients. Scatter, coefficient of variation, bias, precision, accuracy within 30% ranges from the reference method, agreements and receiving operating characteristics (ROC) of each test were compared. Results: ROC analysis identified Davis, Salzar, Virga and Cockcroft-Gault as the most sensitive (≥85%) and the isotope dilution mass spectrometry (IDMS), Edwards, MacIsaac as the most specific (95%) to define the GFR cut-off level of 60 ml/min/1.73 m<sup>2</sup>. Area under the ROC curve (AUC) was generally >0.8 (p ≤ 0.0001). 2 × 2 contingency tables to define CKD demonstrated sensitivity of 90% for Davis, while the IDMS was the most specific (95%). Among the Cys-C-based equations, Filler was the most sensitive (83%) and MacIsaac was the most specific (95%). Conclusion: The current equations lack consistent good performance to define CKD. The MDRD-IDMS equation missed 30% but demonstrated a high specificity to confirm those with moderate CKD. A combination of two equations, one sensitive and another specific, may be required for epidemiological studies.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: found
          • Article: found

          Prediction of Creatinine Clearance from Serum Creatinine

          A formula has been developed to predict creatinine clearance (C cr ) from serum creatinine (S cr ) in adult males: Ccr = (140 – age) (wt kg)/72 × S cr (mg/100ml) (15% less in females). Derivation included the relationship found between age and 24-hour creatinine excretion/kg in 249 patients aged 18–92. Values for C cr were predicted by this formula and four other methods and the results compared with the means of two 24-hour C cr’s measured in 236 patients. The above formula gave a correlation coefficient between predicted and mean measured Ccr·s of 0.83; on average, the difference between predicted and mean measured values was no greater than that between paired clearances. Factors for age and body weight must be included for reasonable prediction.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            The ABCs of Measuring Intracerebral Hemorrhage Volumes

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis.

              Serum cystatin C (Cys C) has been proposed as a simple, accurate, and rapid endogenous marker of glomerular filtration rate (GFR) in research and clinical practice. However, there are conflicting reports regarding the superiority of Cys C over serum creatinine (Cr), with a few studies suggesting no significant difference. We performed a meta-analysis of available data from various studies to compare the accuracy of Cys C and Cr in relation to a reference standard of GFR. A bibliographic search showed 46 articles until December 31, 2001. We also retrieved data from eight other studies presented and published in abstract form. The overall correlation coefficient for the reciprocal of serum Cys C (r = 0.816; 95% confidence interval [CI], 0.804 to 0.826) was superior to that of the reciprocal of serum Cr (r = 0.742; 95% CI, 0.726 to 0.758; P < 0.001). Similarly, receiver operating characteristic (ROC)-plot area under the curve (AUC) values for 1/Cys C had greater identity with the reference test for GFR (mean ROC-plot AUC for Cys C, 0.926; 95% CI, 0.892 to 0.960) than ROC-plot AUC values for 1/Cr (mean ROC-plot AUC for serum Cr, 0.837; 95% CI, 0.796 to 0.878; P < 0.001). Immunonephelometric methods of Cys C assay produced significantly greater correlations than other assay methods (r = 0.846 versus r = 0.784; P < 0.001). In this meta-analysis using currently available data, serum Cys C is clearly superior to serum Cr as a marker of GFR measured by correlation or mean ROC-plot AUC. Copyright 2002 by the National Kidney Foundation, Inc.
                Bookmark

                Author and article information

                Journal
                NEC
                Nephron Clin Pract
                10.1159/issn.1660-2110
                Nephron Clinical Practice
                S. Karger AG
                1660-2110
                2008
                November 2008
                31 October 2008
                : 110
                : 4
                : c195-c206
                Affiliations
                aRoyal University Hospital, Department of Medicine, Division of Nephrology, University of Saskatchewan, Saskatoon, Sask., Canada; bMenoufia University Hospital, Division of Internal Medicine, Menoufia University, Menoufia, Egypt
                Article
                167866 Nephron Clin Pract 2008;110:c195
                10.1159/000167866
                18974650
                2167372b-cd66-4cfa-816f-464390b9d0bf
                © 2008 S. Karger AG, Basel

                Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher. Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug. Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

                History
                : 07 February 2008
                : 22 July 2008
                Page count
                Figures: 2, Tables: 5, References: 59, Pages: 1
                Categories
                Original Paper

                Cardiovascular Medicine,Nephrology
                GFR equations,Glomerular filtration rate,Inulin clearance,Serum creatinine,Cystatin C,Chronic kidney disease

                Comments

                Comment on this article